Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.6500
- TODAY'S CHANGE (%)-0.1300 (-2.7197%)
- Bid / Lots4.6000/ 5
- Ask / Lots4.8200/ 10
- Open / Previous Close4.7700 / 4.7800
- Day Range
- 52 Week Range
- Volume1,780,757
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 12543 | 4.78 |
| 09:34 ET | 1463 | 4.8 |
| 09:36 ET | 5002 | 4.81 |
| 09:38 ET | 4066 | 4.85 |
| 09:39 ET | 14550 | 4.79 |
| 09:41 ET | 2599 | 4.84 |
| 09:43 ET | 16536 | 4.83 |
| 09:45 ET | 2512 | 4.87 |
| 09:48 ET | 4927 | 4.84 |
| 09:50 ET | 3659 | 4.83 |
| 09:52 ET | 2485 | 4.8605 |
| 09:54 ET | 2450 | 4.8801 |
| 09:56 ET | 14350 | 4.92 |
| 09:57 ET | 10535 | 4.935 |
| 09:59 ET | 12598 | 4.99 |
| 10:01 ET | 16092 | 4.94 |
| 10:03 ET | 16931 | 4.97 |
| 10:06 ET | 7175 | 4.93 |
| 10:08 ET | 1548 | 4.925 |
| 10:10 ET | 3900 | 4.9393 |
| 10:12 ET | 6996 | 4.94 |
| 10:14 ET | 1217 | 4.95 |
| 10:15 ET | 12806 | 4.95 |
| 10:17 ET | 25306 | 4.865 |
| 10:19 ET | 26853 | 4.85 |
| 10:21 ET | 11216 | 4.8 |
| 10:24 ET | 7811 | 4.785 |
| 10:26 ET | 4023 | 4.77 |
| 10:28 ET | 21538 | 4.745 |
| 10:30 ET | 18020 | 4.74 |
| 10:32 ET | 2213 | 4.746 |
| 10:33 ET | 12498 | 4.79 |
| 10:35 ET | 2598 | 4.82 |
| 10:37 ET | 13950 | 4.81 |
| 10:39 ET | 3691 | 4.79 |
| 10:42 ET | 1736 | 4.81 |
| 10:44 ET | 2290 | 4.785 |
| 10:46 ET | 1855 | 4.815 |
| 10:48 ET | 800 | 4.8 |
| 10:50 ET | 954 | 4.805 |
| 10:51 ET | 1964 | 4.82 |
| 10:53 ET | 9767 | 4.74 |
| 10:55 ET | 1307 | 4.75 |
| 10:57 ET | 1670 | 4.755 |
| 11:00 ET | 5864 | 4.715 |
| 11:02 ET | 11950 | 4.74 |
| 11:04 ET | 11258 | 4.75 |
| 11:06 ET | 1300 | 4.7402 |
| 11:08 ET | 1000 | 4.75 |
| 11:09 ET | 4431 | 4.73 |
| 11:11 ET | 2303 | 4.725 |
| 11:13 ET | 2521 | 4.75 |
| 11:15 ET | 700 | 4.75 |
| 11:18 ET | 2057 | 4.73 |
| 11:20 ET | 936 | 4.725 |
| 11:22 ET | 1200 | 4.725 |
| 11:24 ET | 2566 | 4.73 |
| 11:26 ET | 5899 | 4.7395 |
| 11:27 ET | 19469 | 4.7495 |
| 11:29 ET | 5465 | 4.77 |
| 11:31 ET | 1155 | 4.78 |
| 11:33 ET | 3600 | 4.7599 |
| 11:36 ET | 1156 | 4.765 |
| 11:38 ET | 9933 | 4.735 |
| 11:40 ET | 900 | 4.735 |
| 11:42 ET | 1024 | 4.74 |
| 11:44 ET | 4354 | 4.76 |
| 11:45 ET | 8692 | 4.765 |
| 11:47 ET | 1700 | 4.75 |
| 11:49 ET | 858 | 4.745 |
| 11:51 ET | 500 | 4.75 |
| 11:54 ET | 500 | 4.75 |
| 11:56 ET | 2254 | 4.735 |
| 11:58 ET | 1200 | 4.73 |
| 12:00 ET | 200 | 4.74 |
| 12:02 ET | 2494 | 4.73 |
| 12:03 ET | 2600 | 4.72 |
| 12:05 ET | 3605 | 4.71 |
| 12:07 ET | 6482 | 4.71 |
| 12:09 ET | 1238 | 4.715 |
| 12:14 ET | 2194 | 4.715 |
| 12:18 ET | 100 | 4.715 |
| 12:20 ET | 300 | 4.715 |
| 12:21 ET | 6632 | 4.7 |
| 12:23 ET | 2208 | 4.705 |
| 12:25 ET | 925 | 4.705 |
| 12:27 ET | 100 | 4.705 |
| 12:30 ET | 1978 | 4.71 |
| 12:32 ET | 29926 | 4.655 |
| 12:34 ET | 5649 | 4.6711 |
| 12:36 ET | 4673 | 4.65 |
| 12:39 ET | 3135 | 4.645 |
| 12:41 ET | 4755 | 4.625 |
| 12:43 ET | 2207 | 4.625 |
| 12:45 ET | 1737 | 4.615 |
| 12:48 ET | 7659 | 4.64 |
| 12:50 ET | 4094 | 4.65 |
| 12:52 ET | 2365 | 4.63 |
| 12:54 ET | 5714 | 4.62 |
| 12:56 ET | 2150 | 4.61 |
| 12:57 ET | 5439 | 4.64 |
| 12:59 ET | 4532 | 4.615 |
| 01:01 ET | 1724 | 4.625 |
| 01:03 ET | 3732 | 4.635 |
| 01:06 ET | 1600 | 4.61 |
| 01:08 ET | 2100 | 4.62 |
| 01:10 ET | 13179 | 4.6301 |
| 01:12 ET | 5127 | 4.61 |
| 01:14 ET | 4675 | 4.6101 |
| 01:15 ET | 3257 | 4.62 |
| 01:17 ET | 1227 | 4.62 |
| 01:19 ET | 200 | 4.6158 |
| 01:21 ET | 900 | 4.62 |
| 01:24 ET | 12362 | 4.655 |
| 01:26 ET | 4457 | 4.67 |
| 01:28 ET | 2300 | 4.67 |
| 01:30 ET | 2227 | 4.67 |
| 01:32 ET | 500 | 4.68 |
| 01:33 ET | 509 | 4.69 |
| 01:35 ET | 300 | 4.69 |
| 01:37 ET | 1400 | 4.71 |
| 01:39 ET | 10136 | 4.69 |
| 01:42 ET | 1087 | 4.685 |
| 01:44 ET | 600 | 4.685 |
| 01:46 ET | 1534 | 4.71 |
| 01:48 ET | 500 | 4.72 |
| 01:50 ET | 200 | 4.72 |
| 01:51 ET | 800 | 4.72 |
| 01:53 ET | 5705 | 4.74 |
| 01:55 ET | 13111 | 4.76 |
| 01:57 ET | 1312 | 4.745 |
| 02:02 ET | 1740 | 4.735 |
| 02:04 ET | 200 | 4.74 |
| 02:06 ET | 600 | 4.735 |
| 02:08 ET | 1000 | 4.74 |
| 02:09 ET | 5754 | 4.74 |
| 02:11 ET | 400 | 4.75 |
| 02:13 ET | 1400 | 4.75 |
| 02:15 ET | 3480 | 4.73 |
| 02:18 ET | 425 | 4.715 |
| 02:20 ET | 500 | 4.72 |
| 02:22 ET | 800 | 4.71 |
| 02:24 ET | 400 | 4.705 |
| 02:27 ET | 1526 | 4.7175 |
| 02:29 ET | 3414 | 4.71 |
| 02:31 ET | 1888 | 4.72 |
| 02:33 ET | 4377 | 4.695 |
| 02:36 ET | 500 | 4.7 |
| 02:38 ET | 581 | 4.69 |
| 02:40 ET | 2715 | 4.685 |
| 02:42 ET | 956 | 4.69 |
| 02:44 ET | 815 | 4.69 |
| 02:45 ET | 600 | 4.69 |
| 02:47 ET | 300 | 4.69 |
| 02:49 ET | 300 | 4.68 |
| 02:51 ET | 905 | 4.685 |
| 02:54 ET | 3919 | 4.7 |
| 02:56 ET | 500 | 4.7 |
| 02:58 ET | 14349 | 4.65 |
| 03:00 ET | 300 | 4.66 |
| 03:02 ET | 600 | 4.65 |
| 03:03 ET | 1250 | 4.657 |
| 03:05 ET | 2575 | 4.665 |
| 03:07 ET | 2300 | 4.665 |
| 03:09 ET | 700 | 4.665 |
| 03:12 ET | 1733 | 4.66 |
| 03:14 ET | 100 | 4.655 |
| 03:18 ET | 3328 | 4.645 |
| 03:20 ET | 1394 | 4.645 |
| 03:21 ET | 3566 | 4.66 |
| 03:23 ET | 3241 | 4.66 |
| 03:25 ET | 1513 | 4.66 |
| 03:27 ET | 1425 | 4.665 |
| 03:30 ET | 2362 | 4.675 |
| 03:32 ET | 2691 | 4.68 |
| 03:34 ET | 700 | 4.685 |
| 03:36 ET | 4412 | 4.695 |
| 03:38 ET | 2567 | 4.7 |
| 03:39 ET | 400 | 4.7 |
| 03:41 ET | 3188 | 4.685 |
| 03:43 ET | 15843 | 4.675 |
| 03:45 ET | 17841 | 4.655 |
| 03:48 ET | 1100 | 4.655 |
| 03:50 ET | 8949 | 4.66 |
| 03:52 ET | 60377 | 4.705 |
| 03:54 ET | 18385 | 4.7 |
| 03:56 ET | 40045 | 4.69 |
| 03:57 ET | 29598 | 4.66 |
| 03:59 ET | 78790 | 4.65 |
May 7, 2024
DJ Summit Therapeutics Initiated at Buy by Citigroup, from 8:27AM ET on Tuesday May 07, 2024 by Dow Jones
8:27AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.4B | -3.0x | --- |
Xenon Pharmaceuticals Inc | 3.2B | -14.9x | --- |
SpringWorks Therapeutics Inc | 3.2B | -7.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Biohaven Ltd | 3.7B | -6.3x | --- |
Apogee Therapeutics Inc | 3.0B | -30.6x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Lead Non-Executive Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.26 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
